MedPath

Exciton Technologies Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

EPC Silver Wound Gel (EPC-123) Feasibility Study in the Management of Mildly Infected Diabetic Foot Ulcers

Not Applicable
Completed
Conditions
Non-healing Diabetic Foot Ulcer
Diabetic Foot Infection
Diabetic Foot Ulcer
First Posted Date
2022-02-17
Last Posted Date
2023-09-22
Lead Sponsor
Exciton Technologies Inc.
Target Recruit Count
5
Registration Number
NCT05243810
Locations
🇨🇦

Lawson Health Research Institute, London, Ontario, Canada

Impact of Oxidized Silver Wound Dressings on Wound Bacteria

Not Applicable
Completed
Conditions
Wounds
First Posted Date
2016-01-25
Last Posted Date
2016-01-25
Lead Sponsor
Exciton Technologies Inc.
Target Recruit Count
17
Registration Number
NCT02662101

Trial of exSALT SD7™ Compared to Xeroform® Petrolatum Dressing for the Management of Partial Thickness Donor Sites

Not Applicable
Conditions
Wound Healing
Wound Infection
First Posted Date
2009-08-31
Last Posted Date
2009-12-24
Lead Sponsor
Exciton Technologies Inc.
Target Recruit Count
25
Registration Number
NCT00968994
Locations
🇨🇦

The University of Alberta Hospital, Edmonton, Alberta, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.